{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:27:29Z","timestamp":1791509249658,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Podiatric Medicine and Surgery"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.cpm.2004.05.003","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T10:53:30Z","timestamp":1113821610000},"page":"579-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The systemic treatment of onychomycosis"],"prefix":"10.1016","volume":"21","author":[{"given":"Jay A.","family":"Wenig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cpm.2004.05.003_BIB1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3949\/ccjm.70.2.110","article-title":"Fungal nail infection: assessing the new treatment options","volume":"70","author":"Botek","year":"2003","journal-title":"Cleveland Clin J Med"},{"issue":"Suppl","key":"10.1016\/j.cpm.2004.05.003_BIB2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0190-9622(08)81835-X","article-title":"Kinetics and spectrum of activity of oral antifungals: the therapeutic implications","volume":"29","author":"Meinhof","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archderm.1972.01620120032006","article-title":"Griseofulvin levels in the stratum corneum: study after oral administration in man","volume":"106","author":"Epstein","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB4","first-page":"3464","article-title":"Mycological and clinical evaluation of griseofulvin in onychomycosis","author":"Davies","year":"1967","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.cpm.2004.05.003_BIB5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0733-8635(18)30293-6","article-title":"Onychomycosis agents of choice","volume":"11","author":"Hay","year":"1993","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.cpm.2004.05.003_BIB6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(81)90051-9","article-title":"Cimetidine: adjunct in treatment of tinea capitus","volume":"1","author":"Presser","year":"1981","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.cpm.2004.05.003_BIB7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1439-0507.1989.tb02295.x","article-title":"Toxicological profile and safety evaluation of antifungal azole derivatives","volume":"32","author":"Van Cauteren","year":"1989","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.cpm.2004.05.003_BIB8","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0190-9622(08)81835-X","article-title":"Kinetics and spectrum of activity of oral antifungals: the therapeutic implications","volume":"29","author":"Meinhof","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0190-9622(91)70214-M","article-title":"Ketoconazole-induced fulminant hepatitis necessitating liver transplantation","volume":"25","author":"Knight","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB10","series-title":"Hepatic reactions during ketoconazole treatment: a 1-year update","author":"Janssen","year":"1983"},{"key":"10.1016\/j.cpm.2004.05.003_BIB11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0002-9343(83)90519-3","article-title":"Hepatic reactions during ketoconazole treatment","volume":"74","author":"Janssen","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.cpm.2004.05.003_BIB12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0168-8278(86)80495-0","article-title":"Ketoconazole associated hepatic injury","volume":"3","author":"Stricker","year":"1986","journal-title":"J Hepatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB13","series-title":"Ketoconazole today","first-page":"77","article-title":"Safety in clinical practice","author":"Clissold","year":"1990"},{"issue":"1 Suppl","key":"10.1016\/j.cpm.2004.05.003_BIB14","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0190-9622(08)81838-5","article-title":"Risk\/benefit ratio of modern antifungal therapy: focus on hepatic reactions","volume":"29","author":"Hay","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB15","first-page":"836","article-title":"Commentary: treatment of dermatomycoses with griseofulvin","volume":"118","author":"Blank","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2133.1988.tb03229.x","article-title":"An evaluation of itraconazole in the management of onychomycosis","volume":"119","author":"Hay","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/CMR.1.2.187","article-title":"Overview of medically important antifungal azole derivatives","volume":"1","author":"Fromtling","year":"1988","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cpm.2004.05.003_BIB18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2230.1991.tb00405.x","article-title":"Itraconazole penetrates the nail via the nail matrix and the nail bed: an investigation in onychomycosis","volume":"16","author":"Matthiew","year":"1991","journal-title":"Clin Exp Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.cpm.2004.05.003_BIB19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2230.1992.tb00268.x","article-title":"Treatment of dermatomycoses and onychomycosis\u2014state of the art","volume":"17","author":"Hay","year":"1992","journal-title":"Clin Exp Dermatol"},{"issue":"1 Suppl","key":"10.1016\/j.cpm.2004.05.003_BIB20","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0190-9622(08)81837-3","article-title":"New approaches to the treatment of onychomycosis","volume":"29","author":"Roseeuw","year":"1993","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.cpm.2004.05.003_BIB21","first-page":"326","article-title":"Itraconazole therapy in dermatomycoses and vaginal candidiasis: effects and adverse effects profile in a large multi-center study","volume":"5","author":"Alcantara","year":"1988","journal-title":"Adv Ther"},{"key":"10.1016\/j.cpm.2004.05.003_BIB22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2165\/00003495-198937030-00003","article-title":"Itraconazole\u2014a review","volume":"37","author":"Grant","year":"1989","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.cpm.2004.05.003_BIB23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/120347540200600302","article-title":"Hepatic safety of itraconazole","volume":"6","author":"Gupta","year":"2002","journal-title":"J Cutaneous Med Surg"},{"key":"10.1016\/j.cpm.2004.05.003_BIB24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1525-1470.1999.00050.x","article-title":"Tinea capitis: an overview with emphasis on management","volume":"16","author":"Gupta","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archderm.1992.01680170037002","article-title":"Recalcitrant onychomycosis of the toenails successfully treated with fluconazole","volume":"128","author":"Coldiron","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000247304","article-title":"Onychomycosis: successful treatment with once-weekly fluconazole","volume":"186","author":"Nahss","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.cpm.2004.05.003_BIB27","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0190-9622(98)70490-6","article-title":"Once weekly fluconazole (150, 300 or 450 mg) in the treatment of distal subungual onychomycosis of the toenail","volume":"38","author":"Scher","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1749-6632.1988.tb40456.x","article-title":"New oral treatment for dermatophytosis","volume":"544","author":"Hay","year":"1988","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.cpm.2004.05.003_BIB29","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00003495-199039060-00006","article-title":"Fluconazole\u2014a review","volume":"39","author":"Grant","year":"1990","journal-title":"Drugs"},{"issue":"Suppl 3","key":"10.1016\/j.cpm.2004.05.003_BIB30","first-page":"5327","article-title":"Drug interactions with fluconazole","volume":"12","author":"Lazar","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.cpm.2004.05.003_BIB31","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1126\/science.6547247","article-title":"Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase","volume":"224","author":"Petranyi","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.cpm.2004.05.003_BIB32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/978-1-4612-2762-5_6","article-title":"Allylamine antifungal drugs","volume":"4","author":"Ryder","year":"1991","journal-title":"Curr Top Med Mycol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1525-1470.1998.tb01396.x","article-title":"Onychomycosis in children: prevalence and management","volume":"15","author":"Gupta","year":"1998","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2133.1989.tb08217.x","article-title":"Treatment of dermatophyte infection of the finger- and toe-nails with terbinafine (SF 86-327, Lamisil), an orally active fungicidal agent","volume":"121","author":"Goodfield","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2230.1989.tb00904.x","article-title":"Clinical pharmacokinetics of terbinafine (Lamisil)","volume":"14","author":"Jensen","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2340\/0001555571322326","article-title":"Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat","volume":"71","author":"Ferrgermann","year":"1991","journal-title":"Acta Derm Venereol (Stockh)"},{"issue":"Suppl 39","key":"10.1016\/j.cpm.2004.05.003_BIB37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2133.1992.tb00006.x","article-title":"Pharmacokinetics of terbinafine I the nail","volume":"126","author":"Finlay","year":"1992","journal-title":"Br J Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.cpm.2004.05.003_BIB38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/09546639009089036","article-title":"Clinical results with terbinafine in onychomycosis","volume":"1","author":"Goodfield","year":"1990","journal-title":"J Dermatolog Treat"},{"issue":"Suppl 39","key":"10.1016\/j.cpm.2004.05.003_BIB39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2133.1992.tb00007.x","article-title":"Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial","volume":"126","author":"Goodfield","year":"1992","journal-title":"Br J Dermatol"},{"issue":"Suppl 39","key":"10.1016\/j.cpm.2004.05.003_BIB40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2133.1992.tb00013.x","article-title":"Special features of the clinical use of oral terbinafine in the treatment of fungal diseases","volume":"126","author":"Villars","year":"1992","journal-title":"Br J Dermatol"},{"issue":"Suppl 39","key":"10.1016\/j.cpm.2004.05.003_BIB41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2133.1992.tb00008.x","article-title":"A randomized treatment duration-finding study of terbinafine in onychomycosis","volume":"126","author":"Van Der Schroef","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0738-081X(02)00259-6","article-title":"Management of toe onychomycosis: what is the potential for improving efficacy of treatment?","volume":"20","author":"Gupta","year":"2002","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.cpm.2004.05.003_BIB43","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/0140-6736(92)92081-P","article-title":"Loss of taste and terbinafine [letter]","volume":"339","author":"Johlin","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.cpm.2004.05.003_BIB44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1439-0507.2001.00645.x","article-title":"Age as limiting factor of the efficacy of itraconazole for treatment of onychomycosis","volume":"44","author":"Fiallo","year":"2001","journal-title":"Mycosis"},{"key":"10.1016\/j.cpm.2004.05.003_BIB45","first-page":"211","article-title":"Multiple onychocrytosis following treatment of onychomycosis with oral terbinafine","volume":"66","author":"Weaver Terry","year":"2000","journal-title":"Cutis"},{"key":"10.1016\/j.cpm.2004.05.003_BIB46","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7547\/87507315-89-8-424","article-title":"Onychocryptosis associated with the treatment of onychomycosis","volume":"89","author":"Connelley","year":"1999","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.cpm.2004.05.003_BIB47","first-page":"63","article-title":"Voriconazole","volume":"44","year":"2002","journal-title":"Med Lett Drugs Ther"}],"container-title":["Clinics in Podiatric Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842204000448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842204000448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:49:36Z","timestamp":1760208576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891842204000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0891842204000448"],"URL":"https:\/\/doi.org\/10.1016\/j.cpm.2004.05.003","relation":{},"ISSN":["0891-8422"],"issn-type":[{"value":"0891-8422","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The systemic treatment of onychomycosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Podiatric Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpm.2004.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}